🔗 Permalink

Assignee profile:

Sapreme Technologies B.V.

City:

Bilthoven

Country:

Netherlands

Published Applications:

Last publication date:

2026-01-01

Patent Grants:

Last grant date:

2025-10-28

Top Inventors for applications by Sapreme Technologies B.V.

These are the the leading inventors for applications assigned to Sapreme Technologies B.V.:

Hendrik Fuchs 12 Berlin, Germany
Ruben Postel 12 Utrecht, Netherlands
Lars Stefan Vorthoren 1 Bilthoven, Netherlands
Miriam Verena BUJNY 1 Bilthoven, Netherlands

Ingrid Jolanda de Vries-van Leeuwen 1 Bilthoven, Netherlands
Guy Hermans 1 Merelbeke, Belgium

Recent patent applications by Sapreme Technologies B.V.

Sapreme Technologies B.V. based in Bilthoven, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-01-01

US20260000783A1

Human necessities

ANTIBODY-DRUG CONJUGATE WITH IMPROVED THERAPEUTIC WINDOW

#2 | 2025-10-02

US20250302983A1

Human necessities

Saponin Conjugates

#3 | 2025-06-26

US20250205361A1

Human necessities

TREATMENT REGIMENS FOR THERAPEUTIC EFFECTOR COMPONENTS THAT ACT VIA AN INTRACELLULAR MOLECULAR TARGET

#4 | 2025-06-19

US20250195682A1

Human necessities

IMPROVED CELL-TARGETING BINDING MOLECULE

#5 | 2023-11-09

US20230357310A1

Chemistry; metallurgy

Saponin derivatives with improved therapeutic window

#6 | 2023-06-08

US20230173085A1

Human necessities

Saponin Conjugates

#7 | 2022-10-06 ✅ Patent 12,453,782 granted on 2025-10-28

US20220313834A1

Human necessities

IMPROVED ANTIBODY-OLIGONUCLEOTIDE CONJUGATE

#8 | 2022-08-11

US20220249674A1

Human necessities

BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY

#9 | 2022-07-14

US20220218837A1

Human necessities

DRUG CONJUGATE

#10 | 2022-04-14

US20220111066A1

Human necessities

ANTIBODY-DRUG CONJUGATE WITH IMPROVED THERAPEUTIC WINDOW

#11 | 2022-03-10

US20220072149A1

Human necessities

BIOLOGICALLY ACTIVE CLUSTER OF MOLECULES

#12 | 2022-02-24

US20220054643A1

Human necessities

SAPONIN CONJUGATED TO EPITOPE-BINDING PROTEINS

#13 | 2022-01-27

US20220023433A1

Human necessities

Saponin Conjugates

Also check out SAPREME TECHNOLOGIES B.V.'s (Bilthoven, Netherlands) applicant profile with 15 patent applications submitted.

AssigneeID:

319827 ⎘